10 Stocks with Strong Buy Signals & High Confidence — October 2026

OpportunityRadar Flags 10 Stocks with Robust Buy Signals This October

October 06, 2026 – Our latest OpportunityRadar scan for October 6, 2026, highlights several compelling BUY signals across the market. Leading the charge is Palantir Technologies Inc. (PLTR), which registered the highest OpportunityRadar Score among the top contenders at 70, driven by an impressive fundamental score of 80. PLTR also shows a strong 3-month return of 48.92% and a BUY signal with 83% confidence, indicating significant positive momentum.

Today's scan reveals a strong inclination towards BUY signals, with all 15 identified tickers receiving a BUY signal. Among the top 10 profiled, six tickers — Twist Bioscience (TWST), Agilent Technologies (A), 10x Genomics (TXG), Teekay Tankers (TNK), PubMatic (PUBM), and Worthington Enterprises (WOR) — achieved a perfect 100% confidence rating for their BUY signals and a 'STRONG ENTRY' recommendation. The average Relative Strength Index (RSI) across these top 10 signals sits at 57.85, suggesting generally healthy, non-overbought conditions, while seven of the ten exhibit a BULL MACD indicator, reinforcing positive technical sentiment.

Top 10 Signals at a Glance

#1: PLTR — Palantir Technologies Inc.

Palantir Technologies Inc. (PLTR) registers the highest OpportunityRadar Score in our current scan at 70, underpinned by a robust fundamental score of 80 and a technical score of 64. The stock is currently priced at $192.16 and carries a 'BUY' signal with a substantial confidence rating of 83%, paired with a 'STRONG ENTRY' recommendation. Technical indicators show an RSI of 64.4, positioning it in healthy, non-overbought territory, while the MACD is in a BULL state, suggesting positive momentum. PLTR has demonstrated strong performance over the past three months, with a return of 48.92%, complemented by a 1-month return of 12.84%.

Despite the strong overall score and positive technicals, the Risk/Reward ratio for PLTR stands at 1.2. While this indicates a favorable setup where potential reward outweighs risk, it is not as high as some other signals on the list, suggesting a more balanced risk profile compared to tickers with a 2.0 ratio. Investors should note this relative positioning when evaluating potential entry points.

#2: TWST — Twist Bioscience Corporation

Twist Bioscience Corporation (TWST) presents a compelling 'BUY' signal with a perfect 100% confidence rating and a 'STRONG ENTRY' recommendation, reflecting strong alignment across its underlying components. The company holds an OpportunityRadar Score of 64, with a technical score of 70 and a fundamental score of 55. Priced at $177.74, TWST's technical posture includes an RSI of 57.3 and a MACD in a BULL state, indicating positive price action. The stock has delivered exceptional returns, surging 38.79% over the last month and an impressive 89.75% over the past three months.

The Risk/Reward ratio for TWST is notably high at 2.0, suggesting a significant potential upside relative to the downside risk identified by the scanner. While this is generally a positive indicator, the high 3-month return of 89.75% might lead some investors to consider if a portion of this strong performance has already been realized, although the current technicals and 100% confidence signal continue to support a positive outlook.

#3: A — Agilent Technologies, Inc.

Agilent Technologies, Inc. (A) is another ticker flashing a 'BUY' signal with a 100% confidence rating and a 'STRONG ENTRY' recommendation from OpportunityRadar. The stock, trading at $170.24, has an overall score of 64, comprising a technical score of 68 and a fundamental score of 58. Its technical profile is robust, with an RSI of 62.9 and a MACD in a BULL state, both supporting the positive signal. Agilent has shown solid price appreciation, with a 1-month return of 15.93% and a 3-month return of 27.43%.

One aspect to consider for Agilent is its Risk/Reward ratio, which is 0.4. This low ratio suggests that the potential reward, as measured by the scanner, is less than the identified risk. While the 100% confidence and strong technicals are positive, the relatively unfavorable Risk/Reward ratio warrants close attention for those prioritizing risk-adjusted returns.

#4: TXG — 10x Genomics, Inc.

10x Genomics, Inc. (TXG) stands out with a 'BUY' signal and a perfect 100% confidence rating, along with a 'STRONG ENTRY' recommendation. The stock, priced at $84.23, carries an OpportunityRadar Score of 63, with a technical score of 68 and a fundamental score of 55. Technical indicators are favorable, showing an RSI of 56.9 and a MACD in a BULL state. TXG has delivered impressive short-term performance, with a 1-month return of 28.4% and an outstanding 3-month return of 95.43%, making it the top 3-month performer among the profiled tickers.

With a Risk/Reward ratio of 2.0, 10x Genomics indicates a strong potential for reward relative to risk, which aligns with its high confidence signal. However, the substantial 3-month gain of 95.43% could imply that a significant portion of its upward move has already occurred. While the scanner continues to flag a 'STRONG ENTRY', investors should be mindful of the rapid ascent in recent months.

#5: TNK — Teekay Tankers Ltd.

Teekay Tankers Ltd. (TNK) is identified with a 'BUY' signal and a 100% confidence rating, warranting a 'STRONG ENTRY' recommendation. Currently trading at $101.87, TNK has an OpportunityRadar Score of 63, featuring a technical score of 69 and a fundamental score of 53. The stock's technical strength is evident with an RSI of 64.9, approaching the upper bound of the neutral range, and a MACD in a BULL state. TNK has shown consistent positive returns, with a 1-month gain of 10.33% and a 3-month gain of 47.06%.

Similar to Agilent, Teekay Tankers has a Risk/Reward ratio of 0.4. This low ratio suggests that the potential reward for this signal is limited compared to the identified risk. While the 100% confidence signal is compelling, the conservative Risk/Reward ratio indicates that the upside potential may be constrained, or the downside risk is relatively higher, despite the positive technical momentum.

#6: PUBM — PubMatic, Inc.

PubMatic, Inc. (PUBM), priced at $18.77, has triggered a 'BUY' signal with a 100% confidence rating and a 'STRONG ENTRY' recommendation. The company scores 63 on the OpportunityRadar, with a technical score of 71 and a fundamental score of 50. Its technical indicators are positive, including an RSI of 63.6 and a MACD in a BULL state. PUBM has seen a 15.22% increase over the last month and a 38.42% rise over the past three months, demonstrating solid upward trajectory.

The Risk/Reward ratio for PubMatic is 0.4, which is on the lower end among today's signals. This implies that the potential reward is relatively small when compared to the identified risk. Despite the strong technical momentum and perfect confidence rating, the low Risk/Reward ratio suggests that investors should carefully evaluate the potential upside against the downside exposure.

#7: WOR — Worthington Enterprises, Inc.

Worthington Enterprises, Inc. (WOR) is another stock showing a 'BUY' signal with a 100% confidence rating and a 'STRONG ENTRY' recommendation. The stock is trading at $61.63 and holds an OpportunityRadar Score of 63, with a technical score of 67 and a fundamental score of 56. Its technical picture includes an RSI of 58.3 and a MACD in a BULL state, indicating favorable momentum. Over the past three months, WOR has returned 16.81%, although its 1-month return is slightly negative at -1.25%.

The 1-month return of -1.25% for Worthington Enterprises stands out as the only negative 1-month return among the top 10 profiled tickers, despite the 100% confidence 'BUY' signal. While the 3-month return remains positive, this recent dip suggests a potential short-term pullback that investors should monitor, even with the overall strong signal alignment and a Risk/Reward ratio of 1.0.

#8: NEOG — Neogen Corporation

Neogen Corporation (NEOG), priced at $12.33, has generated a 'BUY' signal with a 67% confidence rating and an 'ENTRY' recommendation. The stock's OpportunityRadar Score is 62, with a technical score of 68 and a fundamental score of 53. NEOG's technical indicators show an RSI of 47.8, which is in a neutral range, but its MACD is in a BEAR state. The company has posted a 1-month return of 3.7% and a 3-month return of 26.46%.

A key divergence for Neogen is the MACD being in a BEAR state despite a 'BUY' signal. While the overall confidence is 67% and the Risk/Reward is a favorable 1.8, the bearish MACD suggests that momentum may be waning or has recently turned negative, which could introduce volatility. This technical divergence warrants careful consideration for potential investors.

#9: FLGT — Fulgent Genetics, Inc.

Fulgent Genetics, Inc. (FLGT) registers a 'BUY' signal with an 83% confidence rating and a 'STRONG ENTRY' recommendation. Trading at $20.92, FLGT has an OpportunityRadar Score of 62, composed of a technical score of 68 and a fundamental score of 53. The technical analysis shows an RSI of 48.4, indicating neutral conditions, but the MACD is in a BEAR state. The stock has seen a 1-month return of 3.56% and a 3-month return of 0.19%.

Fulgent Genetics exhibits a MACD in a BEAR state, similar to Neogen, despite receiving a 'STRONG ENTRY' signal with 83% confidence. Additionally, its 3-month return of 0.19% is significantly lower than most other profiled tickers, suggesting a lack of sustained upward momentum over the medium term. The Risk/Reward ratio is 1.0, indicating an even balance between potential gain and risk.

#10: TELA — TELA Bio, Inc.

TELA Bio, Inc. (TELA), priced at $1.14, has been flagged with a 'BUY' signal and an 83% confidence rating, along with a 'STRONG ENTRY' recommendation. The stock holds an OpportunityRadar Score of 61, with a technical score of 69 and a fundamental score of 50. Technical indicators show an RSI of 54.0, in a neutral range, but the MACD is in a BEAR state. TELA has demonstrated strong recent performance, with a 1-month return of 37.35% and a 3-month return of 32.87%.

Despite the 'STRONG ENTRY' signal and impressive 1-month return of 37.35%, TELA Bio's MACD is in a BEAR state, which presents a potential technical contradiction. While the Risk/Reward ratio is high at 2.0, suggesting favorable potential, the bearish MACD could indicate underlying weakness or a recent shift in momentum that investors should monitor closely, especially given the stock's lower price point.

Key Observations Across the Scan

Among the 10 tickers profiled, a significant majority, seven, display a MACD in a BULL state, indicating positive momentum. Six of the ten tickers achieved a perfect 100% confidence rating on their BUY signals, highlighting strong alignment across the scanner's confirmation factors. Furthermore, seven out of the ten tickers delivered a 1-month return exceeding 10%, showcasing robust recent performance. The average RSI across these 10 signals is 57.85, suggesting that most are not in overbought territory, maintaining room for potential upward movement according to this indicator.

Key Risk Factors

• Divergent MACD Signals: Neogen Corporation (NEOG), Fulgent Genetics (FLGT), and TELA Bio (TELA) all show a MACD in a BEAR state despite receiving 'BUY' signals. This divergence between the signal and a key momentum indicator like MACD warrants careful consideration, as it could suggest weakening momentum or a recent bearish cross that might impact future performance.
• Low Risk/Reward Ratios: Agilent Technologies (A), Teekay Tankers (TNK), and PubMatic (PUBM) all present a low Risk/Reward ratio of 0.4. This indicates that the potential reward, as calculated by the scanner, is less than the identified risk, suggesting a less favorable risk-adjusted return profile compared to other opportunities.
• Recent Negative 1-Month Performance: Worthington Enterprises (WOR) recorded a -1.25% 1-month return, standing out as the only negative short-term performer among the top 10, despite its 100% confidence 'BUY' signal. This recent dip could signal short-term headwinds that might persist, even with positive longer-term (3-month) returns and strong confidence.

About Our Methodology

OpportunityRadar scans 6,600+ US stocks daily using 15+ technical indicators including RSI, MACD, Bollinger Bands, ADX, Aroon, support/resistance levels, and volume analysis, combined with fundamental metrics. Stocks are scored 0-100 with signals ranging from Accumulate to Strong Buy. Entry confidence is rated 50-100% based on 6 confirmation factors.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Data as of October 06, 2026.